Q1 INTERIM REPORT

January - March

2022

Presentation

CEO Håkan Lagerberg CFO Jenny Graflind

Q1 2022 Highlights

2 new acquisitions & Strong start of the year

New acquisitions - NaturVet & Innovet

Organic growth 7% - 2022 target 20%

New product launches from many brands

Several Expos in Europe and USA

Business development - Wide offering

Net sales (MSEK)

400

350

300

250

182%

200

100

90

80

70

60

50

Operational

EBITDA (MSEK)

158%

150

100

50

134,0377,7

40

30

20

10

36,7

94,7

27,4%

24,9%

0

Q1 2021

Q1 2022

-

Q1 2021

Q1 2022

Key Performance Indicators

Q1 2022

Sales per region Q1

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Swedencare AB published this content on 28 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 July 2022 06:47:02 UTC.